News
Study finds dosing strategy may affect immunotherapy outcomes
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based
How human cells and pathogenic shigella engage in battle
One member of a large protein family that is known to stop the spread of bacterial infections by prompting infected human cells to self-destruct appears to kill the infectious bacteria instead.